Effects of chronic urticaria on ovarian reserve

Year 2023, , 772 - 774, 30.07.2023

Mehmet Ak , Mustafa Taş , Hüseyin Aksoy , Ragıp Ertaş

https://doi.org/10.32322/jhsm.1264177

Abstract

Aims: To evaluate the ovarian reserve in women with chronic urticaria (CU).
Methods: Thirty women with CU and twenty nine healthy controls were enrolled in this study. Serum levels of anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), estradiol (E2), and luteinizing hormone (LH) were measured on cycle day 2. All patients underwent transvaginal ultrasonographic examination on the second day of their menstrual cycle to assess Antral Follicle Count (AFC) and ovarian volume (OV). The disease activity of CU was measured with the urticaria control test (UCT) and urticaria activity score (UAS).
Results: Women with CU had significantly lower concentrations of AMH, AFC, and E2 than controls. Additionally, total AFC and ovarian volume were significantly lower in women with CU than in the control group. UAS and UCT were positively associated with FSH and negatively associated with AMH, AFC, and OV.
Conclusion: This is the first prospective controlled study to examine ovarian reserve in women with CU. In this study, we found that ovarian reserve was significantly reduced in women with CU. CU may negatively affect the ovarian reserve but the mechanism of this effect is unclear.

Keywords

Antral follicle count, ovarian volume, anti-Müllerian hormone, chronic urticaria

References

• O’Donnel BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on quality of life. Br J Dermatol 1997;136(2):197-201.
• Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/ APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766.
• Ertaş R, Özyurt K, Yıldız S, Ulaş Y, Turasan A, Avcı A. Adverse reaction to omalizumab in patients with chronic urticaria:flare up or ineffectiveness?. Iran J Allergy, Asthma Immunol. 2016;15(1):82–86.
• Ertaş R, Özyurt K, Karakükçü Ç, et al. Evaluation of platelet parameters and neutrophil/lymphocyte ratio during omalizumab treatment in patients with severe chronic spontaneous urticaria. Turkish J Med Sci. 2018;48(6):1255–1262.
• Eliakim R, Sherer DM. Celiac disease: fertility and pregnancy. Gynecol Obstet Invest. 2001;51(1):3-7.
• Tuğrul Ayanoğlu B, Özdemir ED, Türkoğlu O, Alhan A. Diminished ovarian reserve in patients with psoriasis. Taiwan J Obstet Gynecol. 2018;57(2):227-230.
• Cakmak E, Karakus S, Demirpence O, Demet Coskun B. Ovarian reserve assessment in celiac patients of reproductive age. Med Sci Monit. 2018;24:1152-1157.
• Loverro G, Nappi L, Mei L, Giacomoantonio L, Carriero C, Tartagni M. Evaluation of functional ovarian reserve in 60 patients. Reprod Biomed Online. 2003;7(2):200-204.
• Ruggeri RM, Vita G, D'Angelo AG, et al. The unusual association of Graves' disease, chronic spontaneous urticaria, and premature ovarian failure:report of a case and HLA haplotype characterization. Arq Bras Endocrinol Metabol. 2013;57(9):748-752.
• Şahin A, Karakuş S, Durmaz Y, et al. Evaluation of ovarian reserve with anti-Müllerian hormone in familial Mediterranean fever. Int J Rheumatol. 2015:380354.
• Ertaş R, Erol K. The frequency of chronic widespread pain and its impact on quality of life in patients with chronic spontaneous urticaria. Konuralp Med J. 2019;11(1):101-105.
• Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJM. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation:a metaanalysis. Human Reproduction Update. 2011;17(1):46–54.
• Reshef T, David BS. Ovarian reserve testing:a user’s guide. Am J Obstet Gynecol. 2017;217(2):129-140.
• Kruszyńska A, Słowińska-Srzednicka, J. Anti-Müllerian hormone (AMH) as a good predictor of time of menopause. Menopause Review/Przegląd Menopauzalny. 2017;16(2):47-50.
• Henes M, Froeschlin J, Taran FA, et al. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases:impact of rheumatoid arthritis, Behçet’s disease and spondyloarthritis on anti-Müllerian hormone levels. Rheumatology. 2015;54(9):1709-1712.
• Carp HJ, Selmi C, Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. J Autoimmunity. 2012;38(2-3):266-274.
• Cutolo M, Straub RH. Sex steroids and autoimmune rheumatic diseases:state of the art. Nat Rev Rheumatol. 2020;16(11):628-644.
• Giménez Arnau AM, Grattan C, Zuberbier T, Toubi E. An individualized diagnostic approach based on guidelines for chronic urticaria (CU). J Eur Acad Dermatol Venereol. 2015;29 Suppl 3;3-11.
• Barbakadze L, Kristesashvili J, Khonelidze N, Tsagareishvili G. The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women. Int J Fertil Steril. 2015;8(4):393-398.
• Ahmed TA, Ahmed SM, El-Gammal Z, et al. Oocyte aging:the role of cellular and environmental factors and impact on female fertility. Cell Biol Translat Med Stem Cells Regenerat Med. 2020;8:109-123.